[1]
“Targeting breast cancer using retinoic acid trifloromethyl chalcone: A promising therapeutic strategy in the treatment of breast cancer”, Bangladesh J Pharmacol, vol. 10, no. 1, pp. 209–213, Mar. 2015, doi: 10.3329/bjp.v10i1.21599.